Access count of this item: 98

Files in This Item:
File Description SizeFormat 
16_0473.pdf575.09 kBAdobe PDFView/Open
Title: 前立腺肥大症に対するSH-582(gestonorone caproate)の効果
Other Titles: Effects of SH 582 (gestonorone caproate) for prostatic hypertrophy
Authors: 落合, 京一郎  KAKEN_name
駒瀬, 元治  KAKEN_name
大島, 博幸  KAKEN_name
根岸, 荘治  KAKEN_name
山内, 昭正  KAKEN_name
Author's alias: Ochiai, Kyoichiro
Komase, Motoharu
Oshima, Hiroyuki
Negishi, Takeharu
Yamauchi, Akimasa
Keywords: Aged
Caproates/adverse effects/pharmacology/therapeutic use
Cell Nucleus/analysis
Injections, Subcutaneous
Middle Aged
Pregnanes/adverse effects/pharmacology/therapeutic use
Prostatic Hyperplasia/drug therapy
Urination/drug effects
Issue Date: Sep-1970
Publisher: 泌尿器科紀要刊行会
Journal title: 泌尿器科紀要
Volume: 16
Issue: 9
Start page: 473
End page: 481
Abstract: The effects of SH 582 were investigated in 28 patients with prostatic hypertrophy who could be followed-up for more than 3 months. Urinary frequency, dysuria and residual urine volume were improved in about 60 %, 70 % and 50 %, respectively. Palpation of the prostate demonstrated reduction of the adenoma in about 25 %, which could not be confirmed by the x-ray visualization of the urethra. Estimation of DNA within the epithelial cell nuclei of the prostate did not reveal any influence due to SH 582. When SH 582 was administered to mature male rats in an attempt to see possible changes in the manner of steroidgenesis in the testis, there was no evidence that activities of various enzymes participating in the production of male sex hormones were reduced in the treated group as compared with the control. There were no significant changes in weight of the testis of the treated animals. However, weight of their prostate showed a significant reduction when compared with the control.
PubMed ID: 4097359
Appears in Collections:Vol.16 No.9

Show full item record

Export to RefWorks

Export Format: 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.